AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 4348475 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine oestrogen
Number of subjects: 0
Study 4348475 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 495529 — intervention group
Group type: EXPERIMENTAL
Intervention: Written recall
Number of subjects: 80
Study 495529 — intervention group
Group type: COMPARATOR
Intervention: Spoken recall
Number of subjects: 80
Study 495529 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 80
Study 495529 — intervention group
Group type: COMPARATOR
Intervention: Task-motivation
Number of subjects: 80
Study 495529 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially amnesic subjects
Number of subjects: 80
Study 495529 — intervention group
Group type: COMPARATOR
Intervention: Full recall subjects
Number of subjects: 80
Study 495529 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrecall subjects
Number of subjects: 80
Study 495529 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic subjects
Number of subjects: 80
Study 29771314 — intervention group
Group type: EXPERIMENTAL
Intervention: Bibloc appliance
Number of subjects: 302
Study 29771314 — intervention group
Group type: COMPARATOR
Intervention: Monobloc appliance
Number of subjects: 302
Study 29257754 — intervention group
Group type: EXPERIMENTAL
Intervention: rs6535454 in patients with SAMS (GG=51.1%, GA=40.0%, AA=8.9%)
Number of subjects: 1129
Study 29257754 — intervention group
Group type: EXPERIMENTAL
Intervention: rs4693075 in patients suffering SAMS (CC=36.8%, CG=48.2%, GG=15.0%)
Number of subjects: 1129
Study 29257754 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype distributions
Number of subjects: 1129
Study 26282654 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutations in CCND1 and DNA repair pathway alterations (TP53, ATM, ATR, ZNFHX4)
Number of subjects: 463
Study 26282654 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutations in IRF4 and EGR1
Number of subjects: 463
Study 26282654 — intervention group
Group type: EXPERIMENTAL
Intervention: International staging system mutation score
Number of subjects: 463
Study 23692303 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg
Number of subjects: 13
Study 23692303 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 20562170 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone treatment
Number of subjects: 0
Study 20562170 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen pre-treatment
Number of subjects: 0
Study 20562170 — intervention group
Group type: COMPARATOR
Intervention: Buspirone after placebo
Number of subjects: 0
Study 20562170 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone after estrogen pre-treatment
Number of subjects: 0
Study 19393480 — intervention group
Group type: EXPERIMENTAL
Intervention: Monascus purpureus Went rice
Number of subjects: 72
Study 19393480 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 72
Study 19393480 — intervention group
Group type: COMPARATOR
Intervention: Control group (no anti-dyslipidemic therapy)
Number of subjects: 72
Study 18693971 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-test after 0 days
Number of subjects: 91
Study 18693971 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-test after 8 days
Number of subjects: 91
Study 18693971 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-test after 55 days
Number of subjects: 91
Study 18693971 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear regression modeling
Number of subjects: 91
Study 15448310 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional stimuli (high arousal negative, low arousal positive)
Number of subjects: 146
Study 15448310 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional stimuli (varied valence and arousal)
Number of subjects: 146
Study 15448310 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional stimuli (Studies 1, 6, and 7)
Number of subjects: 146
Study 11219208 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary radiation therapy
Number of subjects: 0
Study 11219208 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (angioplasty and stenting)
Number of subjects: 0
Study 9538975 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfonylurea plus metformin
Number of subjects: 591
Study 9538975 — intervention group
Group type: COMPARATOR
Intervention: Sulfonylurea alone
Number of subjects: 591
Study 7735924 — intervention group
Group type: EXPERIMENTAL
Intervention: metronidazole+tetracycline+bismuth subcitrate
Number of subjects: 164
Study 7735924 — intervention group
Group type: COMPARATOR
Intervention: omeprazole+amoxycillin+bismuth subcitrate
Number of subjects: 164
Study 2690897 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial primary prevention intervention (5-year trial)
Number of subjects: 612
Study 2690897 — intervention group
Group type: COMPARATOR
Intervention: Randomised non-treated control group
Number of subjects: 612
Study 2690897 — intervention group
Group type: COMPARATOR
Intervention: Non-randomised low risk group
Number of subjects: 612
Study 4558903 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of Delta(9)‐tetrahydrocannabinol and 11‐OH‐Delta(9)‐tetrahydrocannabinol
Number of subjects: 0
Study 31618272 — intervention group
Group type: EXPERIMENTAL
Intervention: intermittent theta burst stimulation (iTBS) applied to the left dorsolateral prefrontal cortex
Number of subjects: 38
Study 31618272 — intervention group
Group type: COMPARATOR
Intervention: sham stimulation (control)
Number of subjects: 38
Study 27767354 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthokeratology contact lenses (OK)
Number of subjects: 30
Study 27767354 — intervention group
Group type: COMPARATOR
Intervention: Distance single-vision spectacles (SV) (Control group)
Number of subjects: 30
Study 26008626 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional cross-linking (Group I, 36 patients, 3 mW/cm(2) for 30 min)
Number of subjects: 138
Study 26008626 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated cross-linking (Group II, 36 patients, 9 mW/cm(2) for 10 min)
Number of subjects: 138
Study 26008626 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated cross-linking (Group III, 33 patients, 18 mW/cm(2) for 5 min)
Number of subjects: 138
Study 26008626 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated cross-linking (Group IV, 33 patients, 30 mW/cm(2) for 3 min)
Number of subjects: 138
Study 23663534 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based meditation intervention (8 weekly sessions, 90 min each)
Number of subjects: 28
Study 23663534 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (no intervention during the study period)
Number of subjects: 28
Study 21859484 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized beclomethasone dipropionate (BDP) 400 μg b.i.d. plus nebulized salbutamol 2500 μg prn
Number of subjects: 166
Study 21859484 — intervention group
Group type: COMPARATOR
Intervention: Nebulized placebo plus nebulized salbutamol 2500 μg prn
Number of subjects: 166
Study 18762410 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.6g of plant sterol-enriched low-fat fermented milk (FM)
Number of subjects: 116
Study 18762410 — intervention group
Group type: COMPARATOR
Intervention: Control FM product
Number of subjects: 116
Study 17317044 — intervention group
Group type: EXPERIMENTAL
Intervention: Early home-based intervention with monthly specific home visits between the infant ages of 5 and 9 months
Number of subjects: 95
Study 17317044 — intervention group
Group type: COMPARATOR
Intervention: Routine center-based services (Control)
Number of subjects: 95
Study 15266884 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg
Number of subjects: 50
Study 15266884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 11929404 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg once a day
Number of subjects: 15
Study 11929404 — intervention group
Group type: COMPARATOR
Intervention: Famotidine 20 mg twice a day
Number of subjects: 15
Study 9842390 — intervention group
Group type: EXPERIMENTAL
Intervention: Social-influences tobacco prevention program with a booster intervention
Number of subjects: 0
Study 9842390 — intervention group
Group type: COMPARATOR
Intervention: Health education as usual (Control)
Number of subjects: 0
Study 7978397 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (SEVO)
Number of subjects: 34
Study 7978397 — intervention group
Group type: COMPARATOR
Intervention: Halothane (HALO)
Number of subjects: 34
Study 2916514 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (Theo-Dur tablets, 14 to 16 mg/kg per day or their usual dose, whichever was higher)
Number of subjects: 17
Study 2916514 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 2916514 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 17
Study 768909 — intervention group
Group type: EXPERIMENTAL
Intervention: acebutolol 500 mg
Number of subjects: 47
Study 768909 — intervention group
Group type: EXPERIMENTAL
Intervention: bendrofluazide 5-15 mg
Number of subjects: 47
Study 768909 — intervention group
Group type: EXPERIMENTAL
Intervention: acebutolol and bendrofluazide in association
Number of subjects: 47
Study 768909 — intervention group
Group type: EXPERIMENTAL
Intervention: acebutolol alone
Number of subjects: 47
Study 768909 — intervention group
Group type: EXPERIMENTAL
Intervention: bendrofluazide alone
Number of subjects: 47
Study 29393173 — intervention group
Group type: EXPERIMENTAL
Intervention: Needlescopic Cholecystectomy (NSC)
Number of subjects: 105
Study 29393173 — intervention group
Group type: COMPARATOR
Intervention: Single-Incision Laparoscopic Cholecystectomy (SILC)
Number of subjects: 105
Study 28449690 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg iron as NaFeEDTA
Number of subjects: 338
Study 28449690 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg iron as encapsulated ferrous fumarate
Number of subjects: 338
Study 28449690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 338
Study 25429421 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (SLT)
Number of subjects: 100
Study 25429421 — intervention group
Group type: COMPARATOR
Intervention: Prostaglandin analog (PGA; travoprost, 0.004%)
Number of subjects: 100
Study 24079756 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health training program for primary care health workers
Number of subjects: 20
Study 24079756 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mental health training)
Number of subjects: 20
Study 21171844 — intervention group
Group type: EXPERIMENTAL
Intervention: Television Assisted Prompting (TAP) system
Number of subjects: 3
Study 21171844 — intervention group
Group type: COMPARATOR
Intervention: Typical practice delivery conditions
Number of subjects: 3
Study 20021666 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrabenazine (TBZ), maximum dosage of 200 mg/day, titrated to the best individual dose over 80 weeks.
Number of subjects: 75
Study 17476515 — intervention group
Group type: EXPERIMENTAL
Intervention: Ilizarov external fixation (IEF)
Number of subjects: 61
Study 17476515 — intervention group
Group type: COMPARATOR
Intervention: Unreamed tibial nailing (UTN)
Number of subjects: 61
Study 15152555 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfetin (biological preparation)
Number of subjects: 0
Study 11265776 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical instillation of recombinant IL-2
Number of subjects: 27
Study 9408712 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral change
Number of subjects: 0
Study 9408712 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational studies
Number of subjects: 0
Study 8326370 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 43
Study 8326370 — intervention group
Group type: EXPERIMENTAL
Intervention: Acepromazine
Number of subjects: 43
Study 8326370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 8326370 — intervention group
Group type: EXPERIMENTAL
Intervention: Premedicants (Diazepam, Acepromazine, Placebo)
Number of subjects: 43
Study 2938993 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin
Number of subjects: 0
Study 2938993 — intervention group
Group type: COMPARATOR
Intervention: Minocycline
Number of subjects: 0
Study 30047357 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure in vivo (EXP), a cognitive-behavioral treatment targeting pain-related fear
Number of subjects: 46
Study 30047357 — intervention group
Group type: COMPARATOR
Intervention: Pain-contingent physical therapy (PPT)
Number of subjects: 46
Study 27146814 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole (40 mg ID for 2 days)
Number of subjects: 16
Study 27146814 — intervention group
Group type: COMPARATOR
Intervention: Rosuvastatin (10 mg) alone
Number of subjects: 16
Study 24277351 — intervention group
Group type: EXPERIMENTAL
Intervention: Resourcefulness training reinforced by expressive writing
Number of subjects: 102
Study 24277351 — intervention group
Group type: EXPERIMENTAL
Intervention: Resourcefulness training reinforced by verbal disclosure
Number of subjects: 102
Study 24277351 — intervention group
Group type: COMPARATOR
Intervention: Expressive writing
Number of subjects: 102
Study 24277351 — intervention group
Group type: COMPARATOR
Intervention: Verbal disclosure
Number of subjects: 102
Study 24277351 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 102
Study 22307571 — intervention group
Group type: EXPERIMENTAL
Intervention: Trophic enteral feeding for the first 6 days
Number of subjects: 1000
Study 22307571 — intervention group
Group type: COMPARATOR
Intervention: Full enteral feeding for the first 6 days
Number of subjects: 1000
Study 19702471 — intervention group
Group type: EXPERIMENTAL
Intervention: Coerced complement nouns
Number of subjects: 0
Study 19702471 — intervention group
Group type: EXPERIMENTAL
Intervention: Animacy-violated complement nouns
Number of subjects: 0
Study 19702471 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentence-final words in coerced sentences
Number of subjects: 0
Study 17319919 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (QD, n=50)
Number of subjects: 143
Study 17319919 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (BID, n=46)
Number of subjects: 143
Study 17319919 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (QD and BID, n=50 and n=46)
Number of subjects: 143
Study 17319919 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=47)
Number of subjects: 143
Study 16260822 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioral therapy with minimal therapist contact plus participation in a discussion group
Number of subjects: 0
Study 16260822 — intervention group
Group type: COMPARATOR
Intervention: Participation in a discussion group only (waiting-list control group)
Number of subjects: 0
Study 12137110 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrostatic anti-G suit (Libelle; L)
Number of subjects: 3
Study 12137110 — intervention group
Group type: COMPARATOR
Intervention: Pneumatic anti-G ensemble (AGE-39) with full anti-G straining maneuvers (FM)
Number of subjects: 3
Study 12137110 — intervention group
Group type: COMPARATOR
Intervention: Pneumatic anti-G ensemble (AGE-39) with reduced anti-G straining maneuvers (RM)
Number of subjects: 3
Study 10594422 — intervention group
Group type: EXPERIMENTAL
Intervention: rocuronium (20 mg)
Number of subjects: 116
Study 10594422 — intervention group
Group type: COMPARATOR
Intervention: vecuronium (4 mg)
Number of subjects: 116
Study 7540426 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 523
Study 7540426 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 523
Study 7540426 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 523
Study 1280803 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid
Number of subjects: 19
Study 1280803 — intervention group
Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 19
Study 3866411 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.5% with Ganda 1.0/0.2
Number of subjects: 35
Study 3866411 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.25% with Ganda 1.0/0.2
Number of subjects: 35
Study 3866411 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.5%
Number of subjects: 35
Study 3866411 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.25%
Number of subjects: 35
Study 30723945 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucosal incision-assisted biopsy (MIAB)
Number of subjects: 47
Study 30723945 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA)
Number of subjects: 47
Study 29752528 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Aid (DA) counseling
Number of subjects: 336
Study 29752528 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling (Control)
Number of subjects: 336
Study 26207797 — intervention group
Group type: EXPERIMENTAL
Intervention: Ubiquinone
Number of subjects: 60
Study 26207797 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 60
Study 26207797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 25604606 — intervention group
Group type: EXPERIMENTAL
Intervention: FeSS protocols implementation
Number of subjects: 111
Study 25604606 — intervention group
Group type: EXPERIMENTAL
Intervention: Preimplementation workshops
Number of subjects: 111
Study 25604606 — intervention group
Group type: EXPERIMENTAL
Intervention: Postimplementation survey
Number of subjects: 111
Study 23580744 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon with conventional anticoagulation (activated clotting time >250 s)
Number of subjects: 34
Study 23580744 — intervention group
Group type: EXPERIMENTAL
Intervention: Multipolar duty‐cycled radiofrequency ablation
Number of subjects: 34
Study 23580744 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary vein ablation catheter with aggressive anticoagulation (activated clotting time >320 s)
Number of subjects: 34
Study 20942267 — intervention group
Group type: EXPERIMENTAL
Intervention: Joba exercise (30-min session per day, 7 times per week, for 3 months)
Number of subjects: 24
Study 20942267 — intervention group
Group type: COMPARATOR
Intervention: Normal lifestyle (control group)
Number of subjects: 24
Study 19140462 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal anesthesia (ETA) with medial approach for resection of segmented intestine and its tumours with colostomy or ileostomy (n = 154) and primary interintestinal anastomoses (n = 18).
Number of subjects: 552
Study 19140462 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial laparotomy under ETA with internal or external colonic decompression without tumour resection.
Number of subjects: 552
Study 19140462 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive decompressive ileostomy or colostomy under local anesthesia after premedication.
Number of subjects: 552
Study 16637909 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (IV)
Number of subjects: 37
Study 16637909 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study 12812862 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (synthetic estrogens)
Number of subjects: 226
Study 12812862 — intervention group
Group type: EXPERIMENTAL
Intervention: Variation in estrogen levels
Number of subjects: 226
Study 12812862 — intervention group
Group type: COMPARATOR
Intervention: Oral Contraceptive (OC) use
Number of subjects: 226
Study 10816903 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention to physical sensations
Number of subjects: 81
Study 10816903 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction from physical sensations
Number of subjects: 81
Study 7632156 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath alcohol monitor (Alcomed 3010)
Number of subjects: 0
Study 7632156 — intervention group
Group type: COMPARATOR
Intervention: Gas chromatography (GC)
Number of subjects: 0
Study 2507321 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratracheal surfactant (SF‐RI 1) application
Number of subjects: 10
Study 2507321 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study 45463 — intervention group
Group type: EXPERIMENTAL
Intervention: Lergotrile mesylate (2 mg oral)
Number of subjects: 16
Study 31345056 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronotropic Incompetence (CI) group (n = 472)
Number of subjects: 599
Study 31345056 — intervention group
Group type: COMPARATOR
Intervention: No-Chronotropic Incompetence (no-CI) group (n = 177)
Number of subjects: 599
Study 31345056 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate reserve
Number of subjects: 599
Study 31345056 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak VO2
Number of subjects: 599
Study 31302338 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback (BF)
Number of subjects: 34
Study 31302338 — intervention group
Group type: COMPARATOR
Intervention: Non-biofeedback (NBF)
Number of subjects: 34
Study 28675302 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency endovascular strategy
Number of subjects: 46
Study 28675302 — intervention group
Group type: COMPARATOR
Intervention: Open repair
Number of subjects: 46
Study 28675302 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency endovascular strategy with expert elicitation
Number of subjects: 46
Study 28675302 — intervention group
Group type: COMPARATOR
Intervention: Open repair with expert elicitation
Number of subjects: 46
Study 25568388 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (posterior or anterior arthrodesis)
Number of subjects: 47
Study 25568388 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment (body cast or orthosis)
Number of subjects: 47
Study 23280225 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD Registry patients (MADIT‐II-like)
Number of subjects: 5816
Study 23280225 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD Registry patients (SCD‐HeFT-like)
Number of subjects: 5816
Study 21056418 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20mg/day
Number of subjects: 60
Study 21056418 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10mg/day
Number of subjects: 60